Published in Gene Therapy Weekly, July 13th, 1998
Varicella-zoster virus (VZV) isolates were cultured before (isolate 1) and after (isolate 2) the patient was treated with acyclovir. Virologists A.M. Fillet and associates at the Pitie-Salpetriere Hospital in France assayed the isolates for drug sensitivity using a modified plaque reduction method they described in the Journal of Medical Virology ("Acyclovir-Resistant Varicella-Zoster Virus: Phenotypic and Genetic Characterization," J Med Virol, July...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.